Literature DB >> 32000627

Polycistronic Delivery of IL-10 and NT-3 Promotes Oligodendrocyte Myelination and Functional Recovery in a Mouse Spinal Cord Injury Model.

Dominique R Smith1, Courtney M Dumont1,2,3, Jonghyuck Park4,5, Andrew J Ciciriello1,2, Amina Guo1, Ravindra Tatineni1, Brian J Cummings6,7,8,9, Aileen J Anderson6,7,8,9, Lonnie D Shea1,10.   

Abstract

One million estimated cases of spinal cord injury (SCI) have been reported in the United States and repairing an injury has constituted a difficult clinical challenge. The complex, dynamic, inhibitory microenvironment postinjury, which is characterized by proinflammatory signaling from invading leukocytes and lack of sufficient factors that promote axonal survival and elongation, limits regeneration. Herein, we investigated the delivery of polycistronic vectors, which have the potential to coexpress factors that target distinct barriers to regeneration, from a multiple channel poly(lactide-co-glycolide) (PLG) bridge to enhance spinal cord regeneration. In this study, we investigated polycistronic delivery of IL-10 that targets proinflammatory signaling, and NT-3 that targets axonal survival and elongation. A significant increase was observed in the density of regenerative macrophages for IL-10+NT-3 condition relative to conditions without IL-10. Furthermore, combined delivery of IL-10+NT-3 produced a significant increase of axonal density and notably myelinated axons compared with all other conditions. A significant increase in functional recovery was observed for IL-10+NT-3 delivery at 12 weeks postinjury that was positively correlated to oligodendrocyte myelinated axon density, suggesting oligodendrocyte-mediated myelination as an important target to improve functional recovery. These results further support the use of multiple channel PLG bridges as a growth supportive substrate and platform to deliver bioactive agents to modulate the SCI microenvironment and promote regeneration and functional recovery. Impact statement Spinal cord injury (SCI) results in a complex microenvironment that contains multiple barriers to regeneration and functional recovery. Multiple factors are necessary to address these barriers to regeneration, and polycistronic lentiviral gene therapy represents a strategy to locally express multiple factors simultaneously. A bicistronic vector encoding IL-10 and NT-3 was delivered from a poly(lactide-co-glycolide) bridge, which provides structural support that guides regeneration, resulting in increased axonal growth, myelination, and subsequent functional recovery. These results demonstrate the opportunity of targeting multiple barriers to SCI regeneration for additive effects.

Entities:  

Keywords:  axon elongation; axon myelination; biomaterial; gene therapy; spinal cord injury

Mesh:

Substances:

Year:  2020        PMID: 32000627      PMCID: PMC7310216          DOI: 10.1089/ten.TEA.2019.0321

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  62 in total

1.  Differential vulnerability of propriospinal tract neurons to spinal cord contusion injury.

Authors:  Amanda C Conta; Dennis J Stelzner
Journal:  J Comp Neurol       Date:  2004-11-22       Impact factor: 3.215

Review 2.  Novel combination strategies to repair the injured mammalian spinal cord.

Authors:  Mary Bartlett Bunge
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

Review 3.  The blood-brain barrier.

Authors:  Richard Daneman; Alexandre Prat
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-01-05       Impact factor: 10.005

4.  Channel density and porosity of degradable bridging scaffolds on axon growth after spinal injury.

Authors:  Aline M Thomas; Matthew B Kubilius; Samantha J Holland; Stephanie K Seidlits; Ryan M Boehler; Aileen J Anderson; Brian J Cummings; Lonnie D Shea
Journal:  Biomaterials       Date:  2013-01-02       Impact factor: 12.479

5.  Endothelial NT-3 delivered by vasculature and CSF promotes quiescence of subependymal neural stem cells through nitric oxide induction.

Authors:  Ana C Delgado; Sacri R Ferrón; Diana Vicente; Eva Porlan; Ana Perez-Villalba; Carmen M Trujillo; Pilar D'Ocón; Isabel Fariñas
Journal:  Neuron       Date:  2014-07-18       Impact factor: 17.173

Review 6.  The molecular basis of IL-10 function: from receptor structure to the onset of signaling.

Authors:  Mark R Walter
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

7.  Myelinogenic Plasticity of Oligodendrocyte Precursor Cells following Spinal Cord Contusion Injury.

Authors:  Peggy Assinck; Greg J Duncan; Jason R Plemel; Michael J Lee; Jo A Stratton; Sohrab B Manesh; Jie Liu; Leanne M Ramer; Shin H Kang; Dwight E Bergles; Jeff Biernaskie; Wolfram Tetzlaff
Journal:  J Neurosci       Date:  2017-07-31       Impact factor: 6.167

8.  Long descending cervical propriospinal neurons differ from thoracic propriospinal neurons in response to low thoracic spinal injury.

Authors:  Justin R Siebert; Frank A Middleton; Dennis J Stelzner
Journal:  BMC Neurosci       Date:  2010-11-23       Impact factor: 3.288

9.  Trophic Factors in Inflammation and Regeneration: The Role of MANF and CDNF.

Authors:  Pedro Sousa-Victor; Heinrich Jasper; Joana Neves
Journal:  Front Physiol       Date:  2018-11-20       Impact factor: 4.566

10.  Neural Stem Cells Engineered to Express Three Therapeutic Factors Mediate Recovery from Chronic Stage CNS Autoimmunity.

Authors:  Xing Li; Yuan Zhang; Yaping Yan; Bogoljub Ciric; Cun-Gen Ma; Bruno Gran; Mark Curtis; Abdolmohamad Rostami; Guang-Xian Zhang
Journal:  Mol Ther       Date:  2016-05-16       Impact factor: 11.454

View more
  8 in total

1.  Quercetin Alleviates Demyelination Through Regulating Microglial Phenotype Transformation to Mitigate Neuropsychiatric Symptoms in Mice with Vascular Dementia.

Authors:  Zihu Tan; Guang Yang; Jing Qiu; Wenjing Yan; Yu Liu; Zhengling Ma; Jia Li; Jing Liu; Nan Shan
Journal:  Mol Neurobiol       Date:  2022-03-10       Impact factor: 5.590

Review 2.  Reverse Adverse Immune Microenvironments by Biomaterials Enhance the Repair of Spinal Cord Injury.

Authors:  Hengyi Wang; Yuanliang Xia; Baoqin Li; Yuehong Li; Changfeng Fu
Journal:  Front Bioeng Biotechnol       Date:  2022-05-13

3.  IL-10 lentivirus-laden hydrogel tubes increase spinal progenitor survival and neuronal differentiation after spinal cord injury.

Authors:  Andrew J Ciciriello; Dominique R Smith; Mary K Munsell; Sydney J Boyd; Lonnie D Shea; Courtney M Dumont
Journal:  Biotechnol Bioeng       Date:  2021-04-23       Impact factor: 4.395

4.  Acute Implantation of Aligned Hydrogel Tubes Supports Delayed Spinal Progenitor Implantation.

Authors:  Andrew J Ciciriello; Dominique R Smith; Mary K Munsell; Sydney J Boyd; Lonnie D Shea; Courtney M Dumont
Journal:  ACS Biomater Sci Eng       Date:  2020-09-14

5.  Stem Cell Therapy for Spinal Cord Injury.

Authors:  Liyi Huang; Chenying Fu; Feng Xiong; Chengqi He; Quan Wei
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

6.  Interleukin-10 genetically modified clinical-grade mesenchymal stromal cells markedly reinforced functional recovery after spinal cord injury via directing alternative activation of macrophages.

Authors:  Tianyun Gao; Feifei Huang; Wenqing Wang; Yuanyuan Xie; Bin Wang
Journal:  Cell Mol Biol Lett       Date:  2022-03-17       Impact factor: 5.787

7.  Reduction in post-spinal cord injury spasticity by combination of peripheral nerve grafting and acidic fibroblast growth factor infusion in monkeys.

Authors:  Wei-Ming Sun; Chao-Lin Ma; Jiang Xu; Ji-Ping He
Journal:  J Int Med Res       Date:  2021-06       Impact factor: 1.671

Review 8.  Biomaterial and Therapeutic Approaches for the Manipulation of Macrophage Phenotype in Peripheral and Central Nerve Repair.

Authors:  Adrian Dervan; Antonio Franchi; Francisco R Almeida-Gonzalez; Jennifer K Dowling; Ohemaa B Kwakyi; Claire E McCoy; Fergal J O'Brien; Alan Hibbitts
Journal:  Pharmaceutics       Date:  2021-12-15       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.